Schedule 13G ownership disclosure
Monte Rosa Therapeutics Inc
Security class unavailable · CUSIP: 61225M102
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.0700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-21-000881
- Form type
- SC 13G
- Filer
- Cormorant Asset Management, LP
- CIK
- CIK 1583977
- Filed
- Jul 08, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership